TY  - JOUR
AU  - Cano-Cano, Fatima
AU  - Alcalde-Estevez, Elena
AU  - Gomez-Jaramillo, Laura
AU  - Iturregui, Marta
AU  - Sánchez-Fernandez, Elena M
AU  - Garcia Fernandez, Jose M
AU  - Ortiz Mellet, Carmen
AU  - Campos-Caro, Antonio
AU  - Lopez-Tinoco, Cristina
AU  - Aguilar-Diosdado, Manuel
AU  - Valverde, Angela M
AU  - Arroba, Ana I
PY  - 2021
DO  - 10.3389/fimmu.2021.632132
UR  - http://hdl.handle.net/10668/17531
T2  - Frontiers in immunology
AB  - Diabetic retinopathy (DR) is one of the most common complications of Diabetes Mellitus (DM) and is directly associated with inflammatory processes. Currently, neuro-inflammation is considered an early event in DR and proceeds via microglia...
LA  - en
PB  - Frontiers Research Foundation
KW  - M2 response
KW  - Diabetic retinopathy
KW  - Immunomodulation
KW  - Microglia
KW  - sp2-iminosugar glycolipids
KW  - Animals
KW  - Anti-inflammatory agents
KW  - Cytokines
KW  - Diabetic retinopathy
KW  - Gliosis
KW  - Glycolipids
KW  - Inflammasomes
KW  - Inflammation
KW  - Lipopolysaccharides
KW  - Microglia
KW  - Nitric oxide synthase type II
KW  - Rats
KW  - Retina
KW  - Signal transduction
KW  - Sulfoxides
TI  - Anti-Inflammatory (M2) Response Is Induced by a sp2-Iminosugar Glycolipid Sulfoxide in Diabetic Retinopathy.
TY  - research article
VL  - 12
ER  -